National Center for Complementary and Integrative Health (NCCIH)

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, National Center for Complementary and Integrative Health (NCCIH) sits in the top decile of US sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count).

203 total trials 6 currently recruiting 189 completed early-phase tilt top decile by trial count

National Center for Complementary and Integrative Health (NCCIH): 203 sponsored US clinical trials, 6 recruiting.

National Center for Complementary and Integrative Health (NCCIH) sponsors 203 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 189 completed. 15 of these trials are in Phase 3-4 (later-stage) and 142 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 6 trials.

Top-decile sponsor footprint

National Center for Complementary and Integrative Health (NCCIH) ranks in the top decile of sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 82/100

189 of 195 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

203 total, page 2 of 5

COMPLETED Phase 1

Acupuncture for Irritable Bowel Syndrome

NCT00065403

COMPLETED NA

Chromium Picolinate for the Treatment of Metabolic Syndrome

NCT00128154

COMPLETED Phase 2

Functional Brain Imaging - Acupuncture and Osteoarthritis

NCT00070824

COMPLETED Phase 1

Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia

NCT00080184

COMPLETED Phase 1

IdB 1016 Treatment for Hepatitis C Disease

NCT00055445

COMPLETED Phase 2

REST: Reducing End-of-Life Symptoms With Touch

NCT00065195

COMPLETED Phase 2

Antioxidant Functions of Lipoic Acid

NCT00065624

COMPLETED Phase 1

Amino Acid Therapy for Hot Flashes in Postmenopausal Women

NCT00081952

COMPLETED Phase 2

Acupuncture for Irritable Bowel Syndrome (IBS)

NCT00093327

COMPLETED

Spirituality, Religiosity, and Immune Functioning

NCT00066924

COMPLETED Phase 1

Painful HIV Neuropathy and Alpha-Lipoic Acid

NCT00079807

COMPLETED NA

To Study the Mechanisms of Acupuncture Through Functional Magnetic Resonance Imaging and Peripheral Neurosensory Testing

NCT00521547

COMPLETED Phase 3

PUFA Augmentation in Treatment of Major Depression

NCT00067301

COMPLETED Phase 1

Botanical/Drug Interactions in HIV: Glucuronidation

NCT00065741

TERMINATED Phase 2

Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)

NCT00065234

COMPLETED Phase 2

Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors

NCT00064857

COMPLETED Phase 2

Home Based Massage and Relaxation for Sickle Cell Pain

NCT00066079

COMPLETED Phase 1

Shamanic Healing for Women With Temporomandibular Joint Disorders (TMDs)

NCT00071474

TERMINATED Phase 1

A Study of the Pharmacokinetics of Black Cohosh

NCT00068185

COMPLETED Phase 2

Efficacy of Healing Touch in Stressed Neonates

NCT00034008

COMPLETED Phase 2

Relaxation Response With Acupuncture for HIV Patients

NCT00064740

COMPLETED Phase 2

Pilot Study of Vedic Medicine for Type 2 Diabetes

NCT00065650

COMPLETED Phase 2

Meditation-Based Stress Reduction in Rheumatoid Arthritis

NCT00071292

COMPLETED Phase 1

Black Cohosh Extract in Postmenopausal Breast Health

NCT00064831

COMPLETED Phase 1

Effects of Oral Glucosamine on Insulin and Blood Vessel Activity in Normal and Obese People

NCT00065377

COMPLETED Phase 2

Ginger Control of Chemotherapy Induced Nausea and Vomiting

NCT00065221

COMPLETED Phase 2

Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV

NCT00057538

COMPLETED Phase 2

Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms

NCT00066144

COMPLETED Phase 3

High Intensity Light Therapy in Alzheimer's Disease

NCT00065689

COMPLETED Phase 2

Therapeutic Touch for Wrist Fractures in Postmenopausal Women

NCT00079521

COMPLETED Phase 2

Safety and Effectiveness of Flaxseed for Reducing High Cholesterol

NCT00051415

COMPLETED Phase 2

Massage Therapy for Breast Cancer Treatment-Related Swelling of the Arms

NCT00058851

COMPLETED Phase 1

Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)

NCT00051792

COMPLETED Phase 1

The Efficacy of Reiki in the Treatment of Fibromyalgia

NCT00051428

COMPLETED Phase 2

Phytoestrogens and Memory Decline in Menopause

NCT00051402

COMPLETED Phase 2

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

NCT00070993

COMPLETED Phase 1

Endometriosis : Traditional Medicine vs Hormone Therapy

NCT00034047

COMPLETED Phase 2

Body-Oriented Therapy for Sexual Abuse Recovery

NCT00097305

COMPLETED Phase 2

Healing Touch and Relaxation Therapies in Cervical Cancer Patients

NCT00084123

COMPLETED NA

Acupuncture for the Treatment of Post-Traumatic Stress Disorder (PTSD)

NCT00055354

COMPLETED Phase 2

St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)

NCT00118833

COMPLETED Phase 2

Comparison of Popular Weight Loss Diets

NCT00079573

COMPLETED Phase 1

Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma

NCT00082303

COMPLETED NA

Evaluating Yoga for Chronic Low Back Pain

NCT00056212

TERMINATED Phase 1

Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors

NCT00049608

COMPLETED Phase 2

Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction

NCT00034021

COMPLETED Phase 1

Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer

NCT00034034

COMPLETED Phase 2

St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.

NCT00035438

COMPLETED Phase 2

Magnesium and Asthma - Clinical Trials

NCT00029510

COMPLETED Phase 2

Meaning-Centered Psychotherapy in Advanced Cancer

NCT00067288

← Previous Page 2 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 50
Phase 2 92
Phase 3 14
Phase 4 1

What is open in the National Center for Complementary and Integrative Health (NCCIH) pipeline

6 recruiting of 203 indexed (3% open); 189 completed (93%).

Phase mix: 15 late (III/IV) vs 142 early (I/II) (early-phase heavy).

Top condition: HIV Infections (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

National Center for Complementary and Integrative Health (NCCIH): open-pipeline peers nationwide

Peers matched on 203 registered trials and 3% open enrollment, not the therapeutic-area sidebar.

National Center for Complementary and Integrative Health (NCCIH) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 0%5%10%15%20% Total trials Recruiting share National Center for Complementary and Integrative Health (NCCIH)The University of Texas Medical Branch, GalvestonMedImmuneGenzyme, a Sanofi CompanyOHSU Knight Cancer InstituteIdorsia PharmaceuticalsKlein BuendelKyowa KirinSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
National Center for Complementary and Integrative Health (NCCIH) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

National Center for Complementary and Integrative Health (NCCIH) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 203 trials (± recruiting share)

Sponsors near 3% open enrollment (± trial volume)

What to do with this National Center for Complementary and Integrative Health (NCCIH) page

203 registered trials is a research-attention snapshot, not an endorsement of National Center for Complementary and Integrative Health (NCCIH) or any single study.

  • 6 of National Center for Complementary and Integrative Health (NCCIH)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • HIV Infections is the condition National Center for Complementary and Integrative Health (NCCIH) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

National Center for Complementary and Integrative Health (NCCIH) pipeline card: 203 registered trials from official public datasets.Report a data error.